Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Her is my answer from Hawk on the Royalty payment question
The problem here is not in failure to communicate, but in the failure of shareholders to read and understand what the co. stated. They said in keeping with SEC rules AND PTSC'S INSIDER TRADING POLICY and as I have stated before, this can be anything the co. wants it to be. What part of this do you not understand? They do not have to explain anything. I don't care for all this secrecy either, but legally I believe they're sound. I also believe that we will be recieving money from the J.S going forward and from other co.s also, with a kicker when we are validated by the USPTO. JMO GLTAL RJ
Share
New Message
Please login to post a reply